REFF - Faculty of Philosophy Repository
University of Belgrade - Faculty of Philosophy
    • English
    • Српски
    • Српски (Serbia)
  • English 
    • English
    • Serbian (Cyrillic)
    • Serbian (Latin)
  • Login
View Item 
  •   REFF
  • Psihologija / Psychology
  • Radovi istraživača / Researcher's publications - Odeljenje za psihologiju
  • View Item
  •   REFF
  • Psihologija / Psychology
  • Radovi istraživača / Researcher's publications - Odeljenje za psihologiju
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Screening for metabolic risk factors in women treated for schizophrenia

Authorized Users Only
2013
Authors
Batinić, Borjanka
Đerić-Jeremić, M.
Duisin, Dragana
Opačić, Goran
Article (Published version)
Metadata
Show full item record
Abstract
Metabolic syndrome is a risk factor for cardiovascular disease (CVD) and premature death, especially in people with severe mental illness, such as schizophrenia. Metabolic risk factors are partially attributable to unhealthy lifestyle, including poor diet and lack of regular physical activity, as well as side effects of antipsychotic medications [1−3]. Women diagnosed with schizophrenia and treated with antipsychotic medications constitute a specific subgroup of the population with higher risk for developing metabolic syndrome, and therefore they should be routinely screened and treated for metabolic risk factors. In this pilot study, we investigated the metabolic risk factors among hospitalized women treated for schizophrenia
Source:
European Neuropsychopharmacology, 2013, 23, S467-S468
Publisher:
  • Elsevier Science BV, Amsterdam

DOI: 10.1016/S0924-977X(13)70740-5

ISSN: 0924-977X

WoS: 000209470200626

[ Google Scholar ]
URI
http://reff.f.bg.ac.rs/handle/123456789/1705
Collections
  • Radovi istraživača / Researcher's publications - Odeljenje za psihologiju
Institution/Community
Psihologija / Psychology
TY  - JOUR
AU  - Batinić, Borjanka
AU  - Đerić-Jeremić, M.
AU  - Duisin, Dragana
AU  - Opačić, Goran
PY  - 2013
UR  - http://reff.f.bg.ac.rs/handle/123456789/1705
AB  - Metabolic syndrome is a risk factor
for cardiovascular disease (CVD) and premature death, especially
in people with severe mental illness, such as schizophrenia.
Metabolic risk factors are partially attributable to unhealthy
lifestyle, including poor diet and lack of regular physical activity,
as well as side effects of antipsychotic medications [1−3]. Women
diagnosed with schizophrenia and treated with antipsychotic medications constitute a specific subgroup of the population with
higher risk for developing metabolic syndrome, and therefore they
should be routinely screened and treated for metabolic risk factors.
In this pilot study, we investigated the metabolic risk factors
among hospitalized women treated for schizophrenia
PB  - Elsevier Science BV, Amsterdam
T2  - European Neuropsychopharmacology
T1  - Screening for metabolic risk factors in women treated for schizophrenia
EP  - S468
SP  - S467
VL  - 23
DO  - 10.1016/S0924-977X(13)70740-5
ER  - 
@article{
author = "Batinić, Borjanka and Đerić-Jeremić, M. and Duisin, Dragana and Opačić, Goran",
year = "2013",
abstract = "Metabolic syndrome is a risk factor
for cardiovascular disease (CVD) and premature death, especially
in people with severe mental illness, such as schizophrenia.
Metabolic risk factors are partially attributable to unhealthy
lifestyle, including poor diet and lack of regular physical activity,
as well as side effects of antipsychotic medications [1−3]. Women
diagnosed with schizophrenia and treated with antipsychotic medications constitute a specific subgroup of the population with
higher risk for developing metabolic syndrome, and therefore they
should be routinely screened and treated for metabolic risk factors.
In this pilot study, we investigated the metabolic risk factors
among hospitalized women treated for schizophrenia",
publisher = "Elsevier Science BV, Amsterdam",
journal = "European Neuropsychopharmacology",
title = "Screening for metabolic risk factors in women treated for schizophrenia",
pages = "S468-S467",
volume = "23",
doi = "10.1016/S0924-977X(13)70740-5"
}
Batinić, B., Đerić-Jeremić, M., Duisin, D.,& Opačić, G.. (2013). Screening for metabolic risk factors in women treated for schizophrenia. in European Neuropsychopharmacology
Elsevier Science BV, Amsterdam., 23, S467-S468.
https://doi.org/10.1016/S0924-977X(13)70740-5
Batinić B, Đerić-Jeremić M, Duisin D, Opačić G. Screening for metabolic risk factors in women treated for schizophrenia. in European Neuropsychopharmacology. 2013;23:S467-S468.
doi:10.1016/S0924-977X(13)70740-5 .
Batinić, Borjanka, Đerić-Jeremić, M., Duisin, Dragana, Opačić, Goran, "Screening for metabolic risk factors in women treated for schizophrenia" in European Neuropsychopharmacology, 23 (2013):S467-S468,
https://doi.org/10.1016/S0924-977X(13)70740-5 . .

DSpace software copyright © 2002-2015  DuraSpace
About REFF | Send Feedback

OpenAIRERCUB
 

 

All of DSpaceInstitutions/communitiesAuthorsTitlesSubjectsThis institutionAuthorsTitlesSubjects

Statistics

View Usage Statistics

DSpace software copyright © 2002-2015  DuraSpace
About REFF | Send Feedback

OpenAIRERCUB